Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Barrett

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Parkinsonism & Related Disorders|October 7, 2011
Functional electrical stimulation for the treatment of lower extremity dystoniaMatthew J Barrett, Susan B Bressman, Oren A Levy, et al.
Frontiers in Neurology|May 20, 2020
Cytoarchitectonic Mapping of MRI Detects Rapid Changes in Alzheimer's DiseaseJamie C Blair, Zofia M Lasiecka, James Patrie, et al.
Journal of Parkinson'S Disease|February 19, 2016
Investigation of Genetic Variants Associated with Alzheimer Disease in Parkinson Disease CognitionMatthew J Barrett, Alexander F Koeppel, Joseph L Flanigan, et al.
Research Square|April 10, 2026
Resting-State EEG Features of Cognitive Fluctuations Across the Lewy Body Disease SpectrumAhmed Negida, Sarah K Lageman, Kenchiro Ono, et al.
Neurology|April 6, 2018
Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson diseaseMatthew J Barrett, Jamie C Blair, Scott A Sperling, et al.
Movement Disorders Clinical Practice|November 12, 2021
Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?Matthew J Barrett, Lana Sargent, Huma Nawaz, et al.
Journal of Geriatric Psychiatry and Neurology|March 30, 2017
Diagnostic Accuracy and Confidence in the Clinical Detection of Cognitive Impairment in Early-Stage Parkinson DiseaseKathryn A Wyman-Chick, Phillip K Martin, Matthew J Barrett, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 11, 2024
Optimizing Screening for Intrastriatal Interventions in Huntington's Disease Using Predictive ModelsMatthew J Barrett, Ahmed Negida, Nitai Mukhopadhyay, et al.
The Clinical Neuropsychologist|April 21, 2022
Cholinergic nucleus 4 grey matter density is associated with apathy in Parkinson's diseaseScott A Sperling, Jason Druzgal, Jamie C Blair, et al.
Movement Disorders Clinical Practice|May 13, 2021
The Effect of Education on Symptom Onset and Severity of Huntington's DiseaseKristina K Cain, Joseph L Flanigan, William Alex Dalrymple, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Parkinsonism & Related Disorders|October 7, 2011
Functional electrical stimulation for the treatment of lower extremity dystoniaMatthew J Barrett, Susan B Bressman, Oren A Levy, et al.
Frontiers in Neurology|May 20, 2020
Cytoarchitectonic Mapping of MRI Detects Rapid Changes in Alzheimer's DiseaseJamie C Blair, Zofia M Lasiecka, James Patrie, et al.
Journal of Parkinson'S Disease|February 19, 2016
Investigation of Genetic Variants Associated with Alzheimer Disease in Parkinson Disease CognitionMatthew J Barrett, Alexander F Koeppel, Joseph L Flanigan, et al.
Research Square|April 10, 2026
Resting-State EEG Features of Cognitive Fluctuations Across the Lewy Body Disease SpectrumAhmed Negida, Sarah K Lageman, Kenchiro Ono, et al.
Neurology|April 6, 2018
Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson diseaseMatthew J Barrett, Jamie C Blair, Scott A Sperling, et al.
Movement Disorders Clinical Practice|November 12, 2021
Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?Matthew J Barrett, Lana Sargent, Huma Nawaz, et al.
Journal of Geriatric Psychiatry and Neurology|March 30, 2017
Diagnostic Accuracy and Confidence in the Clinical Detection of Cognitive Impairment in Early-Stage Parkinson DiseaseKathryn A Wyman-Chick, Phillip K Martin, Matthew J Barrett, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 11, 2024
Optimizing Screening for Intrastriatal Interventions in Huntington's Disease Using Predictive ModelsMatthew J Barrett, Ahmed Negida, Nitai Mukhopadhyay, et al.
The Clinical Neuropsychologist|April 21, 2022
Cholinergic nucleus 4 grey matter density is associated with apathy in Parkinson's diseaseScott A Sperling, Jason Druzgal, Jamie C Blair, et al.
Movement Disorders Clinical Practice|May 13, 2021
The Effect of Education on Symptom Onset and Severity of Huntington's DiseaseKristina K Cain, Joseph L Flanigan, William Alex Dalrymple, et al.
Pageof 8